Merck & Co., Inc. (MRK)

122.51 -1.42 (-1.15%) USD  |  NYSE  |  Feb 25, 14:12
More

Merck Accrued Expenses (Quarterly)

Accrued Expenses (Quarterly) Chart

View Accrued Expenses (Quarterly) for MRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accrued Expenses (Quarterly) Range, Past 5 Years

View Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accrued Expenses (Quarterly) Benchmarks

View Accrued Expenses (Quarterly) Benchmarks
Start Trial
Amgen, Inc. Upgrade
Biogen, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Cidara Therapeutics, Inc. Upgrade
Moderna, Inc. Upgrade